A pharmaceuticals company has received fast-track designation from the U.S. Food and Drug Administration for the production of a drug that could possibly prevent malaria in adults.
A pharmaceuticals company has received fast-track designation from the U.S. Food and Drug Administration for the production of a drug that could possibly prevent malaria in adults.
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to: